These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9412777)

  • 1. New lipid lowering drugs and new effects of old drugs.
    Dujovne CA
    Curr Opin Lipidol; 1997 Dec; 8(6):362-8. PubMed ID: 9412777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.
    Spinler SA; Cziraky MJ
    Ann Pharmacother; 1994 Mar; 28(3):343-51. PubMed ID: 8193425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit on atherosclerosis of adding niacin in patients with low HDL-cholesterol taking a statin.
    Amsterdam EA
    Prev Cardiol; 2005; 8(2):130. PubMed ID: 15860992
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adverse effects of lipid-lowering medications].
    Fukumoto Y; Shimokawa H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():165-72. PubMed ID: 18074533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nicotinic acid and the derivative].
    Ogaki S; Matsushima T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():637-41. PubMed ID: 11347146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined treatment: regimens, indications and safety profile].
    Muñiz Grijalvo O; Villar Ortiz J
    Clin Investig Arterioscler; 2013; 25(3):140-5. PubMed ID: 23880257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of hyperlipidemia and the role of probucol.
    Davignon J
    Am J Cardiol; 1986 Jun; 57(16):22H-28H. PubMed ID: 3460320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid lowering drugs in atherosclerosis--the HMG-CoA reductase inhibitors.
    Mantell G
    Clin Exp Hypertens A; 1989; 11(5-6):927-41. PubMed ID: 2676263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrates and niacin: is there a place for them in clinical practice?
    Wierzbicki AS; Viljoen A
    Expert Opin Pharmacother; 2014 Dec; 15(18):2673-80. PubMed ID: 25318657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-atherogenic drugs].
    Kanaki T; Saito Y
    Nihon Rinsho; 1998 Oct; 56(10):2635-9. PubMed ID: 9796331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of lipid-lowering therapies.
    Davidson MH; Toth PP
    Prog Cardiovasc Dis; 2004; 47(2):73-104. PubMed ID: 15586350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
    Tenenbaum A; Fisman EZ; Motro M; Adler Y
    Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycaemic Effects of Non-statin Lipid-Lowering Therapies.
    Collins PD; Sattar N
    Curr Cardiol Rep; 2016 Dec; 18(12):133. PubMed ID: 27864787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drugs of microbial origin for treatment of atherosclerosis].
    Bibikova MV; Bondareva NS
    Antibiot Khimioter; 1998; 43(8):34-9. PubMed ID: 9777104
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug interactions of lipid-altering drugs.
    Bays HE; Dujovne CA
    Drug Saf; 1998 Nov; 19(5):355-71. PubMed ID: 9825949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids and atherosclerosis: clinical management of hypercholesterolaemia.
    Chin-Dusting JP; Shaw JA
    Expert Opin Pharmacother; 2001 Mar; 2(3):419-30. PubMed ID: 11336596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of dyslipidemia: how and when to combine lipid lowering drugs].
    Schulz I
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):344-59. PubMed ID: 16767301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatments for dyslipidemia associated with kidney disease].
    Hirano T; Yoshino G
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():748-52. PubMed ID: 11347167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.